Navigation Links
AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies
Date:10/12/2007

ROCKVILLE, Md., Oct. 12 /PRNewswire-USNewswire/ -- The Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services, announced today the award of $41.6 million over the next 4 years for a new coordinating center and 10 research centers as part of its Centers for Education and Research on Therapeutics program. Four new centers are also added to the CERTs program.

"Expanding the Centers for Education and Research on Therapeutics Program allows AHRQ to build a strong evidence base that consumers, clinicians, and others can use to make critical treatment decisions about therapeutic products and interventions," said AHRQ Director Carolyn M. Clancy, M.D. "The increased number and breadth of expertise in the CERTs will broaden the range of knowledge to help the health care system make measurable improvements in the quality and safety of medications and other treatments and health care."

The new AHRQ-funded CERTs Coordinating Center is Kaiser Permanente's Center for Health Research in Portland, Ore. In addition to assuming infrastructure and leadership support for the CERTs National Steering Committee and research centers, the Center for Health Research will expand the program's ability to translate research findings through collaborations with other research networks, including the National Institutes of Health Roadmap's Clinical Trials Initiative, the NIH Clinical and Translational Science Awards, and AHRQ's Effective Healthcare Program.

In addition to the new coordinating center, there are now 14 CERTs program centers in all. The four new centers receiving first-time funding are:

-- Brigham and Women's Hospital in Boston, which will focus is how health

information technology can improve the safe use of medications

-- The University of Illinois at Chicago, which will focus is how

reinvigorating formularies promote best medication uses

-- Cincinnati's Children's Hospital Medical Center, which will focus is

improving pediatric patient care through projects, such as how

children's metabolism may affect drug effectiveness and safety; and

-- The University of Chicago which will focus is hospital use of

medications and other therapeutics and their clinical and economic

implications.

Six previously funded CERTs research centers won new funding awards. They are: Duke University (therapies for disorders of the heart and blood vessels); Harvard Pilgrim Health Care on behalf of the HMO Research Network (drug use, safety, and effectiveness in defined populations cared for by health plans); University of Alabama at Birmingham (therapies for disorders of the joints and bones); The Arizona CERT at The Critical Path Institute (potentially harmful drug interactions, particularly in women); University of Pennsylvania (therapies for infectious diseases); and Vanderbilt University (prescription drug use in a Medicaid population).

The remaining four centers, which received funding in 2006, are: MD Anderson, Texas (risk and health communication; patient, consumer, and professional education); Rutgers, The State University of New Jersey (mental health therapies); the University of Iowa (improving elderly care, both therapeutics and care management); and the Weill Medical College of Cornell University, New York (therapeutic medical devices).

The CERTs program, which AHRQ administers in partnership with the FDA, was originally authorized by Congress in 1997 to examine the benefits, risks, and cost-effectiveness of therapeutic products; educate patients, consumers, doctors, pharmacists, and other clinical personnel; and improve quality of care while reducing unnecessary costs by increasing appropriate use of therapeutics and preventing adverse effects and their medical consequences. Agency for Healthcare Research and Quality

Contact: AHRQ Public Affairs

(301)427-1258

(301)427-1855


'/>"/>
SOURCE Agency for Healthcare Research and Quality
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Cleveland Clinic Expands Its Services across the World via the Net
2. Ranbaxy Expands By Acquiring A Generic Company In Belgium
3. Insulin and Growth Hormone, Expands Life Span?
4. Health Insurance Company Expands Product Range
5. Bird Flu Outbreak Expands in Vietnam
6. VBI Provides Potential Targets to Diabetes Therapeutics
7. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
8. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
9. Education Levels Found To Predict Stress
10. Education in women brings sounder sleep
11. Education And Income Level May Not Guarantee Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)...   ZirMed Inc ., a recognized leader in cloud-based ... has been ranked #1 by its users for the seventh ... User Survey. ZirMed was recognized as the top-ranked end-to-end revenue ... centers over 200 beds and holds one of the longest ... history. ...
Breaking Medicine Technology: